EV Nickel Inc. | WebDisclosure

Basculer en Français

11313	Companies
251372	Keywords
180476	Articles
137210	Press releases

Home
Companies
EV Nickel Inc.

PRESS RELEASE

published on 09/04/2024 at 13:00, 2 years 2 months ago

EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11%
EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain

Drilling Program Assay Results EV Nickel Inc. High-grade Nickel Canadian Nickel Supply Chain
BRIEF

published on 08/16/2024 at 10:46, 2 years 2 months ago

First Berlin Equity Research Reaffirms BUY Rating for APONTIS PHARMA AG

First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Single Pill Business
BRIEF

published on 08/16/2024 at 10:46, 2 years 2 months ago

First Berlin Equity Research réaffirme la note d'ACHAT pour APONTIS PHARMA AG

APONTIS PHARMA AG Recommandation D'achat Première Recherche Sur Les Actions À Berlin Résultats H1/24 Entreprise De Pilules Individuelles
PRESS RELEASE

published on 08/16/2024 at 10:41, 2 years 2 months ago

Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research recommends buying APONTIS PHARMA AG shares with a target price of €17 after solid H1/24 results and positive outlook. Analyst Christian Orquera maintains his BUY rating

First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Christian Orquera
PRESS RELEASE

published on 08/12/2024 at 18:16, 2 years 2 months ago

Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
Montega AG stuft APONTIS PHARMA AG mit Kaufempfehlung und Kursziel von 16,50 EUR. APONTIS PHARMA zeigt solide Q2-Entwicklung und ermutigende Erfolge in neuer Vertriebsstrategie

Montega AG Kaufempfehlung APONTIS PHARMA AG Kursziel 16,50 EUR Solide Entwicklung
BRIEF

published on 08/09/2024 at 07:35, 2 years 3 months ago

APONTIS PHARMA Reports Strong Half-Year Growth in 2024

Revenue Growth APONTIS PHARMA Single Pill Combinations EBITDA Improvement Novartis Cooperation
BRIEF

published on 08/09/2024 at 07:35, 2 years 3 months ago

APONTIS PHARMA annonce une forte croissance au premier semestre 2024

APONTIS PHARMA Croissance Des Revenus Amélioration De L'EBITDA Combinaisons De Pilules Simples Coopération Avec Novartis
PRESS RELEASE

published on 08/09/2024 at 07:30, 2 years 3 months ago

APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed
APONTIS PHARMA reports profitable revenue growth with Single Pill combinations in the first half of 2024. Forecast for full year 2024 confirmed. Earnings and sales improvements noted

EBITDA Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations
BRIEF

published on 06/27/2024 at 07:35, 2 years 4 months ago

APONTIS PHARMA AG Appoints CFO Thomas Zimmermann to Management Board

Management Board APONTIS PHARMA ESG Strategy Thomas Zimmermann Single Pill
BRIEF

published on 06/27/2024 at 07:35, 2 years 4 months ago

APONTIS PHARMA AG nomme le directeur financier Thomas Zimmermann au conseil d'administration

Conseil D'administration Stratégie ESG PHARMA APONTIS Thomas Zimmermann Pilule Unique

Accesswire

Published on 11/10/2026 at 14:45, 4 hours 8 minutes ago

An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 4 hours 22 minutes ago

First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 4 hours 23 minutes ago

Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 4 hours 23 minutes ago

ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 4 hours 53 minutes ago

Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 18:45, 7 minutes ago

Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 23 minutes ago

Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:29, 24 minutes ago

Designated Person Notification
Published on 11/10/2026 at 18:29, 24 minutes ago

Designated Person Notification
Published on 11/10/2026 at 18:20, 32 minutes ago

Edison issues report on Custodian Property Income REIT (LSE: CREI)

Les Echos

Published on 11/10/2026 at 18:00, 53 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 hour 8 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 1 hour 13 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 1 hour 18 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 hour 21 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE